The Asia Pacific Inhalation Anesthesia Market would witness market growth of 9.5% CAGR during the forecast period (2022-2028).
Inhalational medication development has focused on nontoxic inhalational drugs that allow for fast induction and emergence. The blood/gas solubility coefficient (B/G) and the minimum alveolar concentration are two of the most essential features of inhalational anesthetics (MAC). The B/G refers to the inhaled agent's serum absorption, while the MAC is a measure of a volatile anesthetic's efficacy (i.e., the serum level needed to prevent movement in reaction to a skin incision in 50 percent of patients).
The cardiac effects of diverse inhalational drugs differ not only in B/G and MAC but also in their B/G and MAC. Because of its proclivity for rapid induction and emergence, nitrous oxide (NO) is one of the most regularly employed agents; yet, because of its low potency, it is frequently coupled with other agents.
The main goal of China's health reform is to create a universal basic health care system that provides everyone with safe, effective, convenient, and inexpensive health care. Health finance strategy ensures that financial resources are efficiently distributed and that all population groups, particularly the most vulnerable and high-risk, have access to inexpensive health care.
Over 95 percent of the population in China is covered by the basic health insurance system. The National Healthcare Security Administration was founded in 2018 to oversee all of China's fundamental health insurance plans. Its foundation marks a watershed moment in China's healthcare reform, presenting the potential to further improve the healthcare system's efficiency in terms of cost control, service quality, and value for money. Since the start of health reforms in 2009, China's government health spending has more than tripled, rising from USD 72.44 billion in 2009 to USD 246.48 billion in 2018. Out-of-pocket spending as a percentage of overall health spending fell from 37.46 percent in 2009 to 28.61 percent in 2018 – the lowest level in 20 years.
The China market dominated the Asia Pacific Inhalation Anesthesia Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $148.1 Million by 2028. The Japan market is estimated to grow at a CAGR of 8.9% during (2022 - 2028). Additionally, The India market would witness a CAGR of 10.2% during (2022 - 2028).
Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Maintenance and Induction. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Inhalation Anesthesia Market is Projected to reach USD 1.9 Billion by 2028, at a CAGR of 8.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Piramal Enterprises Limited, Hikma Pharmaceuticals PLC, Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie, Inc., Halocarbon Products Corporation, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., and Troikaa Pharmaceuticals Limited.
Scope of the Study
Market Segments Covered in the Report:
By Drug
- Sevoflurane
- Desflurane
- Isoflurane
- Others
By Application
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Novartis AG
- Piramal Enterprises Limited
- Hikma Pharmaceuticals PLC
- Fresenius SE & Co. KGaA
- Baxter International, Inc.
- AbbVie, Inc.
- Halocarbon Products Corporation
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Lunan Pharmaceutical Group Co., Ltd.
- Troikaa Pharmaceuticals Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Inhalation Anesthesia Market, by Drug
1.4.2 Asia Pacific Inhalation Anesthesia Market, by Application
1.4.3 Asia Pacific Inhalation Anesthesia Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Inhalation Anesthesia Market by Drug
3.1 Asia Pacific Sevoflurane Market by Country
3.2 Asia Pacific Desflurane Market by Country
3.3 Asia Pacific Isoflurane Market by Country
3.4 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Inhalation Anesthesia Market by Application
4.1 Asia Pacific Maintenance Market by Country
4.2 Asia Pacific Induction Market by Country
Chapter 5. Asia Pacific Inhalation Anesthesia Market by Country
5.1 China Inhalation Anesthesia Market
5.1.1 China Inhalation Anesthesia Market by Drug
5.1.2 China Inhalation Anesthesia Market by Application
5.2 Japan Inhalation Anesthesia Market
5.2.1 Japan Inhalation Anesthesia Market by Drug
5.2.2 Japan Inhalation Anesthesia Market by Application
5.3 India Inhalation Anesthesia Market
5.3.1 India Inhalation Anesthesia Market by Drug
5.3.2 India Inhalation Anesthesia Market by Application
5.4 South Korea Inhalation Anesthesia Market
5.4.1 South Korea Inhalation Anesthesia Market by Drug
5.4.2 South Korea Inhalation Anesthesia Market by Application
5.5 Singapore Inhalation Anesthesia Market
5.5.1 Singapore Inhalation Anesthesia Market by Drug
5.5.2 Singapore Inhalation Anesthesia Market by Application
5.6 Malaysia Inhalation Anesthesia Market
5.6.1 Malaysia Inhalation Anesthesia Market by Drug
5.6.2 Malaysia Inhalation Anesthesia Market by Application
5.7 Rest of Asia Pacific Inhalation Anesthesia Market
5.7.1 Rest of Asia Pacific Inhalation Anesthesia Market by Drug
5.7.2 Rest of Asia Pacific Inhalation Anesthesia Market by Application
Chapter 6. Company Profiles
6.1 Novartis AG
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Piramal Enterprises Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Hikma Pharmaceuticals PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Fresenius SE & Co. KGaA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Baxter International, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals and Trials:
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Halocarbon Products Corporation
6.7.1 Company Overview
6.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
6.8.1 Company Overview
6.9 Lunan Pharmaceutical Group Co., Ltd.
6.9.1 Company Overview
6.10. Troikaa Pharmaceuticals Limited
6.10.1 Company Overview
TABLE 1 Asia Pacific Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Sevoflurane Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Sevoflurane Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Desflurane Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Desflurane Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Isoflurane Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Isoflurane Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Maintenance Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Maintenance Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Induction Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Induction Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Inhalation Anesthesia Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Inhalation Anesthesia Market by Country, 2022 - 2028, USD Million
TABLE 21 China Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 22 China Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 23 China Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 24 China Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 25 China Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 26 China Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 27 Japan Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 28 Japan Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 29 Japan Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 30 Japan Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 31 Japan Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 32 Japan Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 33 India Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 34 India Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 35 India Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 36 India Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 37 India Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 38 India Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 39 South Korea Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 40 South Korea Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 41 South Korea Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 42 South Korea Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 43 South Korea Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 44 South Korea Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 45 Singapore Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 46 Singapore Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 47 Singapore Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 48 Singapore Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 49 Singapore Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 50 Singapore Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 51 Malaysia Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 52 Malaysia Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 53 Malaysia Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 54 Malaysia Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 55 Malaysia Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 56 Malaysia Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 57 Rest of Asia Pacific Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 58 Rest of Asia Pacific Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 59 Rest of Asia Pacific Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 60 Rest of Asia Pacific Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 61 Rest of Asia Pacific Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 62 Rest of Asia Pacific Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 63 Key Information – Novartis AG
TABLE 64 Key Information – Piramal Enterprises Limited
TABLE 65 Key Information – Hikma Pharmaceuticals PLC
TABLE 66 key information – Fresenius SE & Co. KGaA
TABLE 67 Key Information – Baxter International, Inc.
TABLE 68 Key information – AbbVie, Inc.
TABLE 69 Key Information – Halocarbon Products Corporation
TABLE 70 Key Information – Jiangsu Hengrui Pharmaceuticals Co., Ltd.
TABLE 71 Key Information – Lunan Pharmaceutical Group Co., Ltd.
TABLE 72 key Information – Troikaa Pharmaceuticals Limited
List of Figures
FIG 1 Methodology for the research